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Oligonucleotides containing a piperazino-
modified 20-amino-LNA monomer exhibit
very high duplex stability and remarkable
nuclease resistance†
Chenguang Lou,a Birte Vesterb and Jesper Wengel*a
Incorporation of a piperazino-modified 20-amino-LNA monomer
(PipLNA-T) into oligonucleotides conferred very high aﬃnity and
base-pairing selectivity towards complementary DNA and RNA strands.
Furthermore, one PipLNA-T modification provided a robust nuclease
resistance that safeguarded three neighbouring natural nucleosides
from 30-exonucleolytic degradation. These favourable properties
render PipLNA-T a promising oligonucleotide modification for various
biological applications.
DNA encodes the genetic information in living organisms and
has attracted extensive and continuous interest in the areas of
biochemistry, biology and nanotechnology within the past few
decades.1–4 Many modified nucleotide monomers have been
incorporated into oligonucleotides (ONs) in order to optimise affinity
and sequence selectivity towards complementary nucleic acids and
to obtain nuclease resistance.5–9 Locked nucleic acid (LNA) mono-
mers represent a class of nucleotides containing ribofuranose units
locked into a C30-endo (North-type) conformation,10,11 and incorpora-
tion of LNA-T and 20-amino-LNA-T monomers (Fig. 1) into ONs
provides increased duplex stability, favorable mismatch discrimina-
tion and improved resistance to nucleolytic digestion.12–16
Besides LNA, the introduction of alkylamine chains into
ONs is recognised as a successful strategy to improve binding
aﬃnity, probably due to electrostatic interactions between the
protonated amine functionalities and the negatively charged
phosphodiester backbone.17–20 Modification of ONs with a piperazino
group introduces a cationic center under physiological conditions,
and provides a possibility for further functionalisation.17,19,21
Therefore, we decided to investigate a piperazino-modified
20-amino-LNA monomer (PipLNA-T; Fig. 1) by combining the
advantageous characteristics of the 20-amino-LNA and piperazino
scaffolds.
Synthesis of the PipLNA-T phosphoramidite monomer 5 was
accomplished in three steps from 3-piperazinopropionic acid (1)
and a DMTr-protected 20-amino-LNA-T precursor 322 (Scheme 1).
The secondary amine of derivative 1 was reacted with N-(9-
fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) in pyridine to
produce 2 in 88% yield. The carboxylic group of 2 was subsequently
reacted with 20-amino-LNA nucleoside 3 in anhydrous DMF in
the presence of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo-
[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) and N,N-
diisopropylethylamine (DIPEA) to give nucleoside 4 in 84% yield,
which was finally phosphitylated by reaction with bis(diisopropyl-
amino)(2-cyanoethoxy)phosphine to provide the desired phosphor-
amidite monomer 5 in 67% yield.
ON synthesis was carried out using standard solid-phase
phosphoramidite chemistry on an automated DNA synthesiser
where the PipLNA-T phosphoramidite monomer 5 was coupled
using a hand-coupling process.23 Fmoc protection of the secondary
amine of PipLNA-T not only prevents it from being irreversibly
acetylated in the capping step of the standard synthesis cycle, but
also allows ON deprotection under mild conditions after completion
of ON synthesis.24,25 The stepwise coupling yield of 20-amino-LNA-T
and PipLNA-T were 96% and 80%, respectively. The imperfect
Fig. 1 Chemical structures of LNA-T, 20-amino-LNA-T and PipLNA-T
monomers.
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coupling eﬃciency on PipLNA-T monomer may result from a
close proximity of the bulky Fmoc-protected piperazino moiety
and the diisopropylamino leaving group.
The synthesised ONs were purified by DMTr-ON reversed-phase
HPLC (and/or ion-exchange HPLC) and their composition and
purity (490%) characterised by MAIDI-TOF MS and ion-exchange
HPLC analysis, respectively.
A 9-mer sequence12,17 was chosen for evaluation of the binding
aﬃnity of PipLNA-containing ONs towards complementary DNA and
RNA strands (Table 1). In comparison with all DNA (ON1) and
20-amino-LNA-T-containing controls (ON2 andON4), ONs containing
one and three PipLNA-Tmodifications were studied (ON3 andON5).
The data show that a PipLNA-T monomer confers substantially
higher duplex stability than thymidine (T) and 20-amino-LNA-T in
DNA–DNA contexts. The same tendency was observed for the
corresponding DNA–RNA hybrids, but with even greater enhance-
ment of stability relative to T and less dramatic difference between
the PipLNA-T and the 20-amino-LNA-T monomers. These hybridisa-
tion data are consistent with previous results showing that ONs
containing 20-amino-LNA-T exhibit higher affinity towards comple-
mentary RNA than DNA,12,26 but show a remarkable additional
affinity-enhancing effect due to the incorporation of the piperazino
group in monomer PipLNA-T.
The eﬀect of PipLNA-T monomers on the thermal stability of
duplexes is cumulative. This is demonstrated by the results that
three PipLNA-T monomers provide far greater duplex stability
than a single modification irrespective of either a DNA or RNA
complementary strand.
In order to determine the importance of protonation of the distal
nitrogen atom of the piperazino moiety (pKaE 9 (ref. 27)), thermal
stability of six duplexes formed by ON1, ON4 and ON5 with
complementary DNA and RNA were evaluated at low salt buﬀer
condition (6.7 mM NaH2PO4–Na2HPO4 buffer and 0.10 mM EDTA,
Table 1). Smaller decreases in melting temperature were found for
the duplexes involving ON5 with three PipLNA-T nucleotides than
for the two control duplexes involvingON1 andON4, suggesting that
decreased duplex stability under low salt conditions can be alleviated
by a stabilising effect from the positively-charged piperazinomoieties
of PipLNA-T. A similar effect was not observed for ON4 containing
three 20-amino-LNA-T monomers, which is consistent with the
reported pKa value of 6.17 for the N20-protonated derivative of the
20-amino-LNA-T monomer.28
The mismatch discrimination ability of the novel PipLNA-T
monomer was assessed for the central position in ON3 and
ON5 in comparison to all-DNA control ON1 (Table S3, ESI†).
Singly-modified ON3 showed higher base-pairing specificity
for its correctly matched complementary strands than ON1,
except for slightly reduced discrimination in the case of the
mismatched RNA target having a cytidine monomer in the
central position. For ON5 (three substitutions with PipLNA-T),
the eﬃcient mismatch discrimination ability of PipLNA-T was
similar to that of DNA-T.
Scheme 1 Reagents and conditions: (i) Fmoc-OSu, DIPEA, pyridine, RT, 12 h, 88%; (ii) 2, HATU, DIPEA, DMF, RT, 1 h, 84%; (iii) bis(diisopropylamino)(2-
cyanoethoxy)phosphine, diisopropylammonium tetrazolide, DCM, 18 h, RT, 67%.
Table 1 Thermal denaturation temperatures of duplexesa
Sequence X
Complementary DNA Complementary RNA
Medium salt Low salt Medium salt Low salt
50-GTGATATGC — ON1 32.0 18.0 29.5 16.0
50-GTGAXATGC 20-Amino-LNA-T ON2 35.5 (+3.5) 37.0 (+7.5)
PipLNA-T ON3 39.0 (+7.0) 38.5 (+9.0)
50-GXGAXAXGC 20-Amino-LNA-T ON4 41.0 (+9.0) 27.5 49.0 (+19.5) 36.0
PipLNA-T ON5 49.5 (+17.5) 39.0 54.0 (+24.5) 42.5
a Tm values (1C) of unmodified and modified (X = 20-amino-LNA-T or PipLNA-T) DNA–DNA and DNA–RNA duplexes measured as an average of two
independent melting temperature determinations with a deviationo0.5 1C. Numbers in brackets are DTm measured as the difference in Tm values
between modified and unmodified duplexes. The experiments were carried out at pH 7.0 in medium salt buffer (5.8 mM NaH2PO4–Na2HPO4
buffer, containing 100 mM NaCl and 0.10 mM EDTA) and low salt buffer (6.7 mM NaH2PO4–Na2HPO4 buffer, containing 0.10 mM EDTA). The
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The ability of the PipLNA-T monomer to partake in triplex
formation was evaluated using a 29-mer dsDNA target containing
the wild-type HIV-1 polypurine tract sequence29 (Table S2, ESI†).
Compared to a wild-type all-DNA TFO (Table S5, ESI†), incorporation
of PipLNA-T greatly improved the triplex stability at both pH 6.0 and
7.0. Interestingly, no obvious improvement in triplex stability was
observed when LNA-T was replaced by PipLNA-T, possibly due to the
short propanoyl tether between the moderately bulky piperizino
group and the nucleoside itself, restricting the conformational
flexibility which could prevent the piperazino group from finding
an optimal position for triplex stabilisation.
Molecular modelling30,31 (Fig. 2) on the duplexON3:DNA with
one PipLNA-T substitution indicated that the 3-(1-piperazino)-
propanoyl group of PipLNA-T is oriented in the minor groove of
the double helix. The distances measured in the model structure
between the protonated amino group of the piperazino ring and the
four nearest negatively-charged oxygen anions on the phosphate
backbone are B8–10 Å, which implies that any favourable electro-
static interaction has to be mediated through water molecule(s)32,33
in the minor groove.
It is known that 20-modified nucleotides usually increase
nuclease resistance of ONs.34–36 In order to evaluate their
resistance towards nucleolytic degradation, we studied the
stability of 50-32P labeled ON1–ON3 upon incubation with snake
venom phosphordiesterase (SVPDE; 30-exonuclease). As shown
in Fig. 3, the unmodified oligonucleotide (X = T, ON1) was
rapidly degraded, with no trace of full-length ON1 left after 10 min
incubation. The degradation progressed over time with bands
corresponding to 3- and 4-mers and 32P-labelled guanosine mono-
phosphate remaining after 60 min. Also ON2 with the central
thymidine substituted by a 20-amino-LNA-T monomer, showed no
full-length product after 15 min incubation. Intriguingly, the degra-
dation was severely inhibited once the TGC-30 triad was digested and
the resulting 50-GTGAXA exhibited very strong nuclease resistance
with only little further digestion after 60 min incubation. This shows
that a 20-amino-LNA-T monomer is much more nuclease-resistant
than its natural counterpart and that it protects the 30-neighbouring
nucleotide from 30-exonucleolytic cleavage.
ON3 (X = PipLNA-T) showed retarded mobility in the gel
compared to ON1 and ON2, probably due to a combination of
reduced overall negative charge because of protonation of the
piperazino moiety and increased bulkiness. Fig. 3 demon-
strates that a single, centrally positioned PipLNA-T monomer
when incorporated into the 9-mer ON induces significantly
improved resistance to SVPDE when compared to both 20-amino-
LNA-T and DNA-T monomers. This counts with respect to full
length product of which a trace remained after 15 min incubation,
but more pronouncedly also by the remarkable stability of the
8-mer product resulting from cleavage of the 30-nucleotide. This
product is well preserved even after 60 min incubation. This
implies that a PipLNA-T modification protects its neighbourhood
up to three natural nucleosides towards its 30-end from 30-exo-
nucleolytic degradation. A similar mechanism has also been
proposed for C5-substituted LNA pyrimidines.20 This behaviour
strongly contrasts that of a single LNA nucleotide which has been
Fig. 2 Modelling structure of a PipLNA-T-modified duplex formed between 50-GTGAXATGC (ON3; green) and its complementary DNA strand (cyan).
The 3-(1-piperazino)propanoyl moiety is marked in magenta. Side views are given from the minor and major grooves.
Fig. 3 20% PAGE denaturing gel showing the time-course of SVPDE-
mediated degradation of 50-32P-GTGAXATGC ON1 (X = T), ON2 (X =
20-amino-LNA-T) and ON3 (X = PipLNA-T) under pH 8.0 at 21 1C. Samples
were incubated for 5, 10, 15, 30 and 60 min. The negative control (0 min)
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reported to confer no or only little resistance towards exonucleolytic
degradation,37,38 and suggests that the PipLNA-modification
may prove uniquely suited for increasing the biostability of
antisense ONs.
In conclusion, a novel PipLNA-T phosphoramidite monomer
has been synthesised from a known 20-amino-LNA-T precursor
and has been incorporated into oligonucleotides. The PipLNA-T
monomer obeys the Watson–Crick base pairing rules, and has a
pronounced stabilising effect on nucleic acid duplexes and triplexes
and a strong stabilising effect against 30-exonucleolytic degradation.
These propertiesmake PipLNA-modified oligonucleotides attractive
in the context of various biomedical and nanotechnological
applications.
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